Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 17, 2025 07:00 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics Presents Clinical Data Updates at the 2025 Tandem Meetings

Autolus Therapeutics Presents Clinical Data Updates at the 2025 Tandem Meetings
January 13, 2025 07:00 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics Provides Business Updates and 2025 Overview

Autolus announces business updates and an overview of 2025 milestones.
December 09, 2024 19:30 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2024

Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2024
December 02, 2024 07:00 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics Announces Publication of Data from the FELIX study of obe-cel in r/r Adult B-ALL Patients in The New England Journal of Medicine

High overall response rate: 76.6% of patients in the pivotal cohort achieved CR/Cri following treatment with obe-cel with a median follow-up of 20.3 monthsLow incidence of immune-related toxicity:...
November 12, 2024 07:00 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics Reports Third Quarter 2024 Financial Results and Business Updates

Autolus Therapeutics Reports Third Quarter 2024 Financial Results and Business Updates
November 08, 2024 16:23 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics Announces FDA Approval of AUCATZYL® (obecabtagene autoleucel – obe-cel) for adults with relapsed/refractory B-cell acute lymphoblastic leukemia (r/r B-ALL)

Autolus Therapeutics Announces FDA Approval of AUCATZYL® (obe-cel) for adults with relapsed/refractory B-cell acute lymphoblastic leukemia
November 05, 2024 09:00 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2024 in One Oral Presentation and Three Poster Presentations

Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2024
October 28, 2024 17:00 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics to Report Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024

Autolus Therapeutics to Report Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024
October 16, 2024 09:00 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics Presents Clinical Data Update at the 2024 Lymphoma, Leukemia & Myeloma Congress

Autolus Therapeutics Presents Clinical Data Update at the 2024 Lymphoma, Leukemia & Myeloma Congress
September 19, 2024 07:00 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics announces appointment of Matthias Will, M.D. as Chief Development Officer

Autolus Therapeutics announces appointment of Matthias Will, M.D. as Chief Development Officer

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right